$THRY
Thryv Holdings, Inc. Stock $thry

$thry Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155673924000015 Filed on February 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$233.6M	$236.2M	$917.0M
YoY Change	-4.86%	-15.47%	-23.74%
Cost Of Revenue	$79.98M	$76.45M	$338.7M
YoY Change	-11.86%	-23.9%	-19.74%
Gross Profit	$153.6M	$159.7M	$578.2M
YoY Change	-0.75%	-10.73%	-25.9%
Gross Profit Margin	65.76%	67.63%	63.06%
Selling, General & Admin	$122.5M	$133.0M	$509.4M
YoY Change	-1.22%	7.55%	-11.99%
% of Gross Profit	79.74%	83.27%	88.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.55M	$16.35M	$37.80M
YoY Change	-5.69%	-27.13%	2.54%
% of Gross Profit	9.47%	10.24%	6.54%
Operating Expenses	$122.5M	$133.0M	$509.4M
YoY Change	-1.22%	7.55%	-11.99%
Operating Profit	$31.13M	$26.72M	-$200.0M
YoY Change	1.13%	-51.64%	-301.38%
Interest Expense	-$13.36M	-$13.82M	$61.73M
YoY Change	-181.02%	-15.33%	2.19%
% of Operating Profit	-42.91%	-51.72%
Other Income/Expense, Net	-$3.954M	$6.331M	-$1.518M
YoY Change	980.33%	-83.85%	-109.83%
Pretax Income	$13.82M	-$249.6M	-$260.5M
YoY Change	0.08%	468.86%	-363.24%
Income Tax	$5.397M	$7.924M	-$1.249M
% Of Pretax Income	39.05%
Net Earnings	$8.424M	-$257.5M	-$259.3M
YoY Change	-9.56%	410.54%	-577.1%
Net Earnings / Revenue	3.61%	-109.05%	-28.28%
Basic Earnings Per Share	$0.24		-$7.47
Diluted Earnings Per Share	$0.22	-$7.35	-$7.47
COMMON SHARES
Basic Shares Outstanding	35.56M shares	35.17M shares	34.72M shares
Diluted Shares Outstanding	37.99M shares		34.72M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.39M	$18.22M	$18.22M
YoY Change	-6.5%	13.63%	13.63%
Cash & Equivalents	$14.39M	$18.22M	$18.22M
Short-Term Investments
Other Short-Term Assets	$49.07M	$2.662M	$37.16M
YoY Change	100.59%	-77.56%	-41.44%
Inventory
Prepaid Expenses
Receivables	$208.7M	$205.5M	$208.4M
Other Receivables	$2.855M	$3.085M	$3.085M
Total Short-Term Assets	$275.0M	$266.9M	$266.9M
YoY Change	-29.23%	-29.46%	-29.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.84M	$38.60M	$38.60M
YoY Change	-0.73%	-8.82%	-8.82%
Goodwill	$299.6M	$302.4M
YoY Change	-46.96%	-46.57%
Intangibles	$11.63M	$18.79M
YoY Change	-64.79%	-45.88%
Long-Term Investments
YoY Change
Other Assets	$162.7M	$28.46M	$156.5M
YoY Change	412.18%	-33.26%	0.0%
Total Long-Term Assets	$511.8M	$516.3M	$516.3M
YoY Change	-34.69%	-35.43%	-35.43%
TOTAL ASSETS
Total Short-Term Assets	$275.0M	$266.9M	$266.9M
Total Long-Term Assets	$511.8M	$516.3M	$516.3M
Total Assets	$786.8M	$783.2M	$783.2M
YoY Change	-32.88%	-33.51%	-33.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.74M	$10.35M	$10.35M
YoY Change	119.86%	-45.46%	-45.46%
Accrued Expenses	$76.97M	$105.9M	$98.17M
YoY Change	-39.5%	-16.49%	-14.15%
Deferred Revenue	$45.85M	$44.56M
YoY Change	-4.05%	6.46%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$52.50M	$70.00M	$70.00M
YoY Change	-25.0%	0.0%	0.0%
Total Short-Term Liabilities	$239.7M	$263.2M	$263.2M
YoY Change	-19.25%	-12.41%	-12.41%
LONG-TERM LIABILITIES
Long-Term Debt	$295.1M	$278.9M	$278.9M
YoY Change	-23.1%	-30.24%	-30.24%
Other Long-Term Liabilities	$85.00M	$19.00M	$88.38M
YoY Change	252.91%	-14.46%	-6.76%
Total Long-Term Liabilities	$380.1M	$367.3M	$367.3M
YoY Change	-20.88%	-25.82%	-25.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$239.7M	$263.2M	$263.2M
Total Long-Term Liabilities	$380.1M	$367.3M	$367.3M
Total Liabilities	$619.8M	$630.5M	$630.5M
YoY Change	-20.26%	-20.76%	-20.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$489.8M	-$498.2M
YoY Change	113.32%	108.53%
Common Stock	$633.0K	$627.0K
YoY Change	2.76%	2.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$167.1M	$152.7M	$152.7M
YoY Change
Total Liabilities & Shareholders Equity	$786.8M	$783.2M	$783.2M
YoY Change	-32.88%	-33.51%	-33.51%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$8.424M	-$257.5M	-$259.3M
YoY Change	-9.56%	410.54%	-577.1%
Depreciation, Depletion And Amortization	$14.55M	$16.35M	$37.80M
YoY Change	-5.69%	-27.13%	2.54%
Cash From Operating Activities	$5.438M	$44.63M	$148.2M
YoY Change	-83.17%	0.62%	-0.23%
INVESTING ACTIVITIES
Capital Expenditures	$7.278M	$10.49M	$33.39M
YoY Change	41.71%	6.13%	14.23%
Acquisitions			$8.897M
YoY Change			-60.97%
Other Investing Activities		-$22.00K	$225.0K
YoY Change
Cash From Investing Activities	-$7.278M	-$10.52M	-$42.52M
YoY Change	41.71%	6.35%	-18.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.558M	-31.39M	-$103.5M
YoY Change	-90.86%	-6.01%	13.61%
NET CHANGE
Cash From Operating Activities	5.438M	44.63M	$148.2M
Cash From Investing Activities	-7.278M	-10.52M	-$42.52M
Cash From Financing Activities	-1.558M	-31.39M	-$103.5M
Net Change In Cash	-3.398M	2.717M	$2.350M
YoY Change	-134.57%	155.6%	-49.17%
FREE CASH FLOW
Cash From Operating Activities	$5.438M	$44.63M	$148.2M
Capital Expenditures	$7.278M	$10.49M	$33.39M
Free Cash Flow	-$1.840M	$34.13M	$114.8M
YoY Change	-106.77%	-0.96%	-3.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6913000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18180000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001556739
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35895
CY2023	dei	Entity Registrant Name EntityRegistrantName	THRYV HOLDINGS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-2740040
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2200 West Airfield Drive, P.O. Box 619810
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	D/FW Airport
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75261
CY2023	dei	City Area Code CityAreaCode	(972)
CY2023	dei	Local Phone Number LocalPhoneNumber	453-7000
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023	dei	Trading Symbol TradingSymbol	THRY
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	800000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35557803	shares
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	916961000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1202388000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1113382000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	338714000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	422006000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	408043000	usd
CY2023	us-gaap	Gross Profit GrossProfit	578247000	usd
CY2022	us-gaap	Gross Profit GrossProfit	780382000	usd
CY2021	us-gaap	Gross Profit GrossProfit	705339000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	300538000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	362432000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	357813000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	208880000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	216406000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	153902000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	268846000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	102222000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3611000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	778264000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	681060000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	515326000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	99322000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	190013000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1070000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-258225000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	46134000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.47
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.78
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34723491	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34336493	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33607446	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34723491	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36506095	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36495746	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18216000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16031000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14926000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14766000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	205503000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	284698000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	35000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	33000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2909000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2583000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3085000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	11553000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17771000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25092000	usd
CY2023Q4	thry	Indemnification Asset Current IndemnificationAssetCurrent	0	usd
CY2022Q4	thry	Indemnification Asset Current IndemnificationAssetCurrent	26495000	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	16722000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	9544000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2662000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2320000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	266868000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	378316000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38599000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42334000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	302400000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	566004000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18788000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	34715000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	128051000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	113859000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28464000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42649000	usd
CY2023Q4	us-gaap	Assets Assets	783170000	usd
CY2022Q4	us-gaap	Assets Assets	1177877000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10348000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	18972000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	105903000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	126810000	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	23979000	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	31919000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	44558000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41854000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	70000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	70000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8402000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10937000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	263190000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	300492000	usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	230052000	usd
CY2022Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	345256000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	48845000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	54554000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	69388000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	72590000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18995000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22718000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	367280000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	495118000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62660783	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35302746	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61279379	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34593837	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	627000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	613000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1151259000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1105701000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	27358037	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26685542	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	485793000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	468879000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15191000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16261000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-498202000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-238907000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	152700000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	382267000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	783170000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1177877000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	196775000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2418000	usd
CY2021	thry	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	13898000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8094000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8047000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	101577000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	314715000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6726000	usd
CY2022	thry	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	64000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14628000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8214000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	54348000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	382267000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6319000	usd
CY2023	thry	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	15898000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22201000	usd
CY2023	thry	Stock Issued During Period Value Settlement Of Indemnification Asset StockIssuedDuringPeriodValueSettlementOfIndemnificationAsset	15760000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1070000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-259295000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-259295000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	54348000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	101577000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63251000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88392000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	105473000	usd
CY2023	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	14954000	usd
CY2022	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	12110000	usd
CY2021	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	11847000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5422000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5749000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4919000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-12904000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-15119000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-20438000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24516000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25971000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19394000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	22201000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	14628000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	8094000	usd
CY2023	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-2719000	usd
CY2022	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-44612000	usd
CY2021	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-14829000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	268846000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	102222000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3611000	usd
CY2023	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-10734000	usd
CY2022	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	2148000	usd
CY2021	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	1000	usd
CY2023	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
CY2022	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	10883000	usd
CY2021	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-603000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2309000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1823000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54325000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5242000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-74368000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	326000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-2764000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5628000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7117000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9592000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5763000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-37749000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-41105000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-125883000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-10750000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-26601000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4397000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	148226000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	148573000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	170571000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	33394000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	29233000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	26849000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6836000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8897000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	22793000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	175370000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	225000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1192000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42516000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52026000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-196575000	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	919975000	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	976296000	usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1046249000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	925684000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	961670000	usd
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1085558000	usd
CY2023	thry	Proceeds From Exercises Of Stock Warrants ProceedsFromExercisesOfStockWarrants	15898000	usd
CY2022	thry	Proceeds From Exercises Of Stock Warrants ProceedsFromExercisesOfStockWarrants	64000	usd
CY2021	thry	Proceeds From Exercises Of Stock Warrants ProceedsFromExercisesOfStockWarrants	13920000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	6318000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	6725000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-103493000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-91097000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39088000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	133000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-827000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1933000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2350000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4623000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11151000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13557000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2406000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20530000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18180000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13557000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	57027000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	57084000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	66737000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9313000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	58259000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	63893000	usd
CY2023	thry	Repurchase Of Treasury Stock As A Result Of The Settlement Of The Indemnification Asset RepurchaseOfTreasuryStockAsAResultOfTheSettlementOfTheIndemnificationAsset	15760000	usd
CY2022	thry	Repurchase Of Treasury Stock As A Result Of The Settlement Of The Indemnification Asset RepurchaseOfTreasuryStockAsAResultOfTheSettlementOfTheIndemnificationAsset	0	usd
CY2021	thry	Repurchase Of Treasury Stock As A Result Of The Settlement Of The Indemnification Asset RepurchaseOfTreasuryStockAsAResultOfTheSettlementOfTheIndemnificationAsset	0	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements requires management to make estimates and assumptions about future events that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. The results of those estimates form the basis for making judgments about the carrying values of certain assets and liabilities.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of reported amounts that rely on significant estimates include revenue recognition, allowance for credit losses, assets acquired and liabilities assumed in business combinations, capitalized costs to obtain a contract, certain amounts relating to the accounting for income taxes, including valuation allowance, indemnification asset, stock-based compensation expense, operating lease right-of-use assets and operating lease liabilities, accrued service credits, and pension obligations. Significant estimates are also used in determining the recoverability and fair value of fixed assets and capitalized software, operating lease right-of-use assets, goodwill and intangible assets.</span></div>
CY2023	thry	Contract With Customer Benefit Period ContractWithCustomerBenefitPeriod	P18M
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	220429000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	299464000	usd
CY2023Q4	thry	Accounts Receivable And Receivables From Contract With Customer Allowance For Credit Loss Current AccountsReceivableAndReceivablesFromContractWithCustomerAllowanceForCreditLossCurrent	14926000	usd
CY2022Q4	thry	Accounts Receivable And Receivables From Contract With Customer Allowance For Credit Loss Current AccountsReceivableAndReceivablesFromContractWithCustomerAllowanceForCreditLossCurrent	14766000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	205503000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	284698000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments subject to concentrations of credit risk consist primarily of trade receivables. The Company deposits cash on hand with major financial institutions. Cash balances at major financial institutions may exceed limits insured by the Federal Deposit Insurance Corporation.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 91%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revenue in all periods presented was derived from sales to local SMBs that operate in limited geographical areas. These SMBs are usually billed in monthly installments when the services begin and, in turn, make monthly payments, requiring the Company to extend credit to these clients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revenue in all periods presented was derived from the sale of marketing services to larger businesses that advertise regionally or nationally. Contracted certified marketing representatives (“</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMRs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) purchase advertising on behalf of these businesses. Payment for advertising is due when the advertising is published and is received directly from the CMRs, net of the CMRs’ commission. The CMRs are responsible for billing and collecting from these businesses. While the Company still has exposure to credit risks, historically, the losses from these clients have been less than that of local SMBs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its operations primarily in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States, Australia and New Zealand. In 2023, the Company's top ten directories, as meas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ured by revenue, accounted for approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of total revenue. No single directory or client accounted for more than </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company’s revenue for the years ended December 31, 2023, 2022 and 2021. Additionally, no single client or CMR accounted for more than </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company’s outstanding accounts receivable as of December 31, 2023 and 2022.</span></div>
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	192000000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	14800000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	29300000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	40800000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	41900000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	51300000	usd
CY2023	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-10700000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	302400000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	1083600000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	566000000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	814800000	usd
CY2023Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	32500000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	192000000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	102000000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.08
CY2021Q4	us-gaap	Goodwill Goodwill	671886000	usd
CY2022	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	102000000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-3882000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	566004000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	268800000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	67000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	302400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18800000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1034751000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1015963000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18788000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P1Y4M24D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1024659000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	989944000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34715000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P1Y9M18D
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25500000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51500000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16120000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2068000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	418000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	139000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	43000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18788000	usd
CY2022Q4	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	14799000	usd
CY2021Q4	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	17475000	usd
CY2020Q4	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	33368000	usd
CY2023	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss Increase Due To Acquisition AccountsReceivableAndContractWithCustomerAllowanceForCreditLossIncreaseDueToAcquisition	0	usd
CY2022	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss Increase Due To Acquisition AccountsReceivableAndContractWithCustomerAllowanceForCreditLossIncreaseDueToAcquisition	0	usd
CY2021	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss Increase Due To Acquisition AccountsReceivableAndContractWithCustomerAllowanceForCreditLossIncreaseDueToAcquisition	2733000	usd
CY2023	thry	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	18664000	usd
CY2022	thry	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	16516000	usd
CY2021	thry	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	8031000	usd
CY2023	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss Write Off AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteOff	18502000	usd
CY2022	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss Write Off AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteOff	19192000	usd
CY2021	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss Write Off AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteOff	26657000	usd
CY2023Q4	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	14961000	usd
CY2022Q4	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	14799000	usd
CY2021Q4	thry	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	17475000	usd
CY2023	thry	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	18700000	usd
CY2022	thry	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	16500000	usd
CY2021	thry	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	8000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14900000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14800000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	100000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	194981000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	171196000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	156382000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	128862000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38599000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42334000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30087000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	29882000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	24886000	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	7709000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	6976000	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	8452000	usd
CY2023	us-gaap	Depreciation Depreciation	37796000	usd
CY2022	us-gaap	Depreciation Depreciation	36858000	usd
CY2021	us-gaap	Depreciation Depreciation	33338000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	57357000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	62044000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	37889000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	52313000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8832000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9799000	usd
CY2023Q4	thry	Accrued Service Credits Current AccruedServiceCreditsCurrent	1825000	usd
CY2022Q4	thry	Accrued Service Credits Current AccruedServiceCreditsCurrent	2654000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	105903000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	126810000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	5834000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	3491000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	4684000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	4600000	usd
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	2600000	usd
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	4800000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	200000	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	3600000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	5201000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9087000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	7684000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	154000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1854000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	1348000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	2389000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	1954000	usd
CY2023	us-gaap	Lease Cost LeaseCost	4007000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8552000	usd
CY2021	us-gaap	Lease Cost LeaseCost	5730000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2716000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4838000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7299000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9780000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5832000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13585000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13131000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23365000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	11997000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	15313000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	14941000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8551000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6054000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14605000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1474000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13131000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	9316000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	14112000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	348897000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	469810000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	70000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	70000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	278897000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	399810000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1100000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1200000	usd
CY2022Q2	thry	Repayments Of Financing Obligations RepaymentsOfFinancingObligations	10200000	usd
CY2021	thry	Financing Obligation Right Of Use Asset Write Off FinancingObligationRightOfUseAssetWriteOff	48100000	usd
CY2021	thry	Financing Obligation Write Off FinancingObligationWriteOff	55200000	usd
CY2021	thry	Gain Loss On Extinguishment Of Financing Obligation GainLossOnExtinguishmentOfFinancingObligation	-3100000	usd
CY2023	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	21386000	usd
CY2022	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	14017000	usd
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	10469000	usd
CY2023	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	13752000	usd
CY2022	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	13534000	usd
CY2021	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	11560000	usd
CY2023	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	407000	usd
CY2022	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	1492000	usd
CY2021	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	374000	usd
CY2023	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	9946000	usd
CY2022	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	43603000	usd
CY2021	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	13364000	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-2719000	usd
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-44612000	usd
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-14829000	usd
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0514
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0277
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0239
CY2023	thry	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Interest Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInterestCostDiscountRate	0.0510
CY2022	thry	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Interest Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInterestCostDiscountRate	0.0237
CY2021	thry	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Interest Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInterestCostDiscountRate	0.0171
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0404
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0318
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0269
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0302
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0302
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0301
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0495
CY2022Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0514
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0351
CY2022Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0302
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	811000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	69388000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	72590000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	69904000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	73401000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	444899000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	591967000	usd
CY2023	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	21386000	usd
CY2022	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	14017000	usd
CY2023	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-501000	usd
CY2022	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	117958000	usd
CY2023	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	57836000	usd
CY2022	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	43127000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	408950000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	444899000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	371498000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	450713000	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	778000	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	23242000	usd
CY2023	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	24605000	usd
CY2022	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-59330000	usd
CY2023	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	57835000	usd
CY2022	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	43127000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	339046000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	371498000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-69904000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-73401000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	409000000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	444900000	usd
CY2023	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1	10400000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	516000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	408950000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	444899000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	408950000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	444899000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	339046000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	371498000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	43942000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	36643000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	35823000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	35447000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	33311000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	148771000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	339046000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	371498000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1.000
CY2022Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1.000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9000000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9200000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	7700000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22201000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14628000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8094000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22201000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14628000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8094000	usd
CY2023	thry	Common Stock Number Of Shares Entitled Per Rsu CommonStockNumberOfSharesEntitledPerRSU	1	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1401467	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	13.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	992723	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	13.20
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	7669	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	10.35
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	401075	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	12.98
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3533507	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.62
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26070000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	0	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	216549	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.22
CY2023	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm	P5Y6M21D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	173000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	7736	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	10.35
CY2023	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsWeightedAverageRemainingContractualTerm	P6Y11M12D
CY2023	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue	91000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3309222	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.65
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28781000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2908147	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.52
CY2023	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P5Y4M20D
CY2023Q4	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue	25682000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3733814	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.59
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M7D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	110298000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	0	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	173709	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.87
CY2022	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm	P6Y2M19D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2908000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	26598	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	11.99
CY2022	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsWeightedAverageRemainingContractualTerm	P7Y5M8D
CY2022	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue	365000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3533507	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.62
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26070000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2132040	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.65
CY2022	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P6Y25D
CY2022Q4	thry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue	17797000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2200000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3100000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2800000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7000000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	1700000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	700000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	1900000	usd
CY2023Q3	thry	Class Of Warrant Or Right Number Of Warrants Unexercised During Period ClassOfWarrantOrRightNumberOfWarrantsUnexercisedDuringPeriod	8253997	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9427343	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5237413	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	24.39
CY2023	thry	Class Of Warrant Or Right Number Of Warrants Exercised During Period ClassOfWarrantOrRightNumberOfWarrantsExercisedDuringPeriod	1173348	shares
CY2022	thry	Class Of Warrant Or Right Number Of Warrants Exercised During Period ClassOfWarrantOrRightNumberOfWarrantsExercisedDuringPeriod	4721	shares
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15900000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	100000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-259295000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	54348000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	101577000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34723491	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34336493	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33607446	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.02
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-259295000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	54348000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	101577000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34723491	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34336493	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33607446	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2169602	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2888300	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34723491	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36506095	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36495746	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.47
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.78
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-278741000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	68706000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	168965000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	18197000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	30269000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-34651000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-260544000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	98975000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	134314000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1870000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	42065000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	31690000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1542000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6579000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5852000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8238000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	11096000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	14494000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11650000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	59740000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	52036000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7789000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9096000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4378000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	826000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3439000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2560000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-5936000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-9456000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-21117000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12899000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15113000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19299000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1249000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	16638000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44627000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32737000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.036
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.091
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.043
CY2023	thry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Indemnification Asset EffectiveIncomeTaxRateReconciliationChangeInFairValueOfIndemnificationAsset	-0.009
CY2022	thry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Indemnification Asset EffectiveIncomeTaxRateReconciliationChangeInFairValueOfIndemnificationAsset	-0.004
CY2021	thry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Indemnification Asset EffectiveIncomeTaxRateReconciliationChangeInFairValueOfIndemnificationAsset	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.018
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.010
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.005
CY2023	thry	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	-0.002
CY2022	thry	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	0.001
CY2021	thry	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	0.042
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.023
CY2023	thry	Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent	0.024
CY2022	thry	Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent	0.019
CY2021	thry	Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent	-0.014
CY2023	thry	Effective Income Tax Rate Reconciliation Bargain Purchase Gain Percent EffectiveIncomeTaxRateReconciliationBargainPurchaseGainPercent	0
CY2022	thry	Effective Income Tax Rate Reconciliation Bargain Purchase Gain Percent EffectiveIncomeTaxRateReconciliationBargainPurchaseGainPercent	-0.022
CY2021	thry	Effective Income Tax Rate Reconciliation Bargain Purchase Gain Percent EffectiveIncomeTaxRateReconciliationBargainPurchaseGainPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.217
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.216
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.006
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.014
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.058
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.017
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.005
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.451
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.244
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4405000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4453000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	16662000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	3790000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	3809000	usd
CY2023Q4	thry	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	9680000	usd
CY2022Q4	thry	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	0	usd
CY2023Q4	thry	Deferred Tax Assets Fixed Assets And Capitalized Fees DeferredTaxAssetsFixedAssetsAndCapitalizedFees	14786000	usd
CY2022Q4	thry	Deferred Tax Assets Fixed Assets And Capitalized Fees DeferredTaxAssetsFixedAssetsAndCapitalizedFees	4552000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	18805000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	20063000	usd
CY2023Q4	thry	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	3474000	usd
CY2022Q4	thry	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	6176000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	4812000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	5039000	usd
CY2023Q4	thry	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	27593000	usd
CY2022Q4	thry	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	28069000	usd
CY2023Q4	thry	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	37615000	usd
CY2022Q4	thry	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	44210000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	15567000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	17033000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8361000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	10077000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	165550000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	160119000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18810000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21109000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	146740000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	139010000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2587000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	8694000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	3368000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	1923000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4489000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4809000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5582000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6270000	usd
CY2023Q4	thry	Deferred Tax Liabilities Debt Capitalized Fees And Other Interest DeferredTaxLiabilitiesDebtCapitalizedFeesAndOtherInterest	0	usd
CY2022Q4	thry	Deferred Tax Liabilities Debt Capitalized Fees And Other Interest DeferredTaxLiabilitiesDebtCapitalizedFeesAndOtherInterest	24000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1099000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	961000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2676000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2983000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	19801000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25664000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	126939000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	113346000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	32700000	usd
CY2023Q4	thry	Deferred Tax Assets Operating Loss Carryforwards Domestic Subject To An Annual Section382 Limitation DeferredTaxAssetsOperatingLossCarryforwardsDomesticSubjectToAnAnnualSection382Limitation	400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	18800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21109000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21338000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2299000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-229000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18810000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21109000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21443000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20834000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	23703000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	624000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	423000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	201000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	332000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	5128000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	146000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2869000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17140000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21443000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20834000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-4300000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	600000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2900000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17100000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21400000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20800000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-2800000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	2100000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	1200000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	9000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	11700000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	9600000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17100000	usd
CY2023Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	15600000	usd
CY2018Q4	thry	Number Of Petitions Filed NumberOfPetitionsFiled	3	petition
CY2018Q4	thry	Number Of Cases Consolidated By Court NumberOfCasesConsolidatedByCourt	3	case
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	4900000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	5500000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	916961000	usd
CY2023	us-gaap	Gross Profit GrossProfit	578247000	usd
CY2023	thry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	187515000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1202388000	usd
CY2022	us-gaap	Gross Profit GrossProfit	780382000	usd
CY2022	thry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	333342000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1113382000	usd
CY2021	us-gaap	Gross Profit GrossProfit	705339000	usd
CY2021	thry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	350523000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-260544000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	98975000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	134314000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	268846000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	102222000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3611000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63251000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88392000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	105473000	usd
CY2023	us-gaap	Interest Expense InterestExpense	61728000	usd
CY2022	us-gaap	Interest Expense InterestExpense	60407000	usd
CY2021	us-gaap	Interest Expense InterestExpense	66374000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22201000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14628000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8094000	usd
CY2023	thry	Restructuring Charges And Integration Expenses RestructuringChargesAndIntegrationExpenses	14612000	usd
CY2022	thry	Restructuring Charges And Integration Expenses RestructuringChargesAndIntegrationExpenses	17804000	usd
CY2021	thry	Restructuring Charges And Integration Expenses RestructuringChargesAndIntegrationExpenses	18145000	usd
CY2023	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-10734000	usd
CY2022	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	2148000	usd
CY2021	thry	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	1000	usd
CY2023	thry	Transaction Costs TransactionCosts	373000	usd
CY2022	thry	Transaction Costs TransactionCosts	6119000	usd
CY2021	thry	Transaction Costs TransactionCosts	25059000	usd
CY2023	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-2719000	usd
CY2022	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-44612000	usd
CY2021	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-14829000	usd
CY2023	thry	Other Income Loss OtherIncomeLoss	-9033000	usd
CY2022	thry	Other Income Loss OtherIncomeLoss	8445000	usd
CY2021	thry	Other Income Loss OtherIncomeLoss	-4283000	usd
CY2023	thry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	187515000	usd
CY2022	thry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	333342000	usd
CY2021	thry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	350523000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	916961000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1202388000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1113382000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	13322000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	18102000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2021	dei	Auditor Firm AuditorFirmId	42

Files In Submission

Name	View Source	Status
0001556739-24-000015-index-headers.html	Edgar Link	pending
0001556739-24-000015-index.html	Edgar Link	pending
0001556739-24-000015.txt	Edgar Link	pending
0001556739-24-000015-xbrl.zip	Edgar Link	pending
exhibit1011-202310xk.htm	Edgar Link	pending
exhibit1011-202310xk001.jpg	Edgar Link	pending
exhibit1011-202310xk002.jpg	Edgar Link	pending
exhibit1011-202310xk003.jpg	Edgar Link	pending
exhibit1011-202310xk004.jpg	Edgar Link	pending
exhibit1011-202310xk005.jpg	Edgar Link	pending
exhibit1011-202310xk006.jpg	Edgar Link	pending
exhibit1011-202310xk007.jpg	Edgar Link	pending
exhibit1012-202310xk.htm	Edgar Link	pending
exhibit1012-202310xk001.jpg	Edgar Link	pending
exhibit1012-202310xk002.jpg	Edgar Link	pending
exhibit1012-202310xk003.jpg	Edgar Link	pending
exhibit1012-202310xk004.jpg	Edgar Link	pending
exhibit1012-202310xk005.jpg	Edgar Link	pending
exhibit1012-202310xk006.jpg	Edgar Link	pending
exhibit1012-202310xk007.jpg	Edgar Link	pending
exhibit1024-202310xk.htm	Edgar Link	pending
exhibit1024-202310xk001.jpg	Edgar Link	pending
exhibit1024-202310xk002.jpg	Edgar Link	pending
exhibit1024-202310xk003.jpg	Edgar Link	pending
exhibit1024-202310xk004.jpg	Edgar Link	pending
exhibit1024-202310xk005.jpg	Edgar Link	pending
exhibit1024-202310xk006.jpg	Edgar Link	pending
exhibit1024-202310xk007.jpg	Edgar Link	pending
exhibit1024-202310xk008.jpg	Edgar Link	pending
exhibit1024-202310xk009.jpg	Edgar Link	pending
exhibit1024-202310xk010.jpg	Edgar Link	pending
exhibit1024-202310xk011.jpg	Edgar Link	pending
exhibit1024-202310xk012.jpg	Edgar Link	pending
exhibit1024-202310xk013.jpg	Edgar Link	pending
exhibit1024-202310xk014.jpg	Edgar Link	pending
exhibit1024-202310xk015.jpg	Edgar Link	pending
exhibit1024-202310xk016.jpg	Edgar Link	pending
exhibit1024-202310xk017.jpg	Edgar Link	pending
exhibit1024-202310xk018.jpg	Edgar Link	pending
exhibit1024-202310xk019.jpg	Edgar Link	pending
exhibit1024-202310xk020.jpg	Edgar Link	pending
exhibit1024-202310xk021.jpg	Edgar Link	pending
exhibit1024-202310xk022.jpg	Edgar Link	pending
exhibit1024-202310xk023.jpg	Edgar Link	pending
exhibit1024-202310xk024.jpg	Edgar Link	pending
exhibit1024-202310xk025.jpg	Edgar Link	pending
exhibit1024-202310xk026.jpg	Edgar Link	pending
exhibit1024-202310xk027.jpg	Edgar Link	pending
exhibit1024-202310xk028.jpg	Edgar Link	pending
exhibit1024-202310xk029.jpg	Edgar Link	pending
exhibit1024-202310xk030.jpg	Edgar Link	pending
exhibit1024-202310xk031.jpg	Edgar Link	pending
exhibit1024-202310xk032.jpg	Edgar Link	pending
exhibit1024-202310xk033.jpg	Edgar Link	pending
exhibit1024-202310xk034.jpg	Edgar Link	pending
exhibit1024-202310xk035.jpg	Edgar Link	pending
exhibit1024-202310xk036.jpg	Edgar Link	pending
exhibit1024-202310xk037.jpg	Edgar Link	pending
exhibit1024-202310xk038.jpg	Edgar Link	pending
exhibit1024-202310xk039.jpg	Edgar Link	pending
exhibit1024-202310xk040.jpg	Edgar Link	pending
exhibit1024-202310xk041.jpg	Edgar Link	pending
exhibit1024-202310xk042.jpg	Edgar Link	pending
exhibit1024-202310xk043.jpg	Edgar Link	pending
exhibit1024-202310xk044.jpg	Edgar Link	pending
exhibit1024-202310xk045.jpg	Edgar Link	pending
exhibit1024-202310xk046.jpg	Edgar Link	pending
exhibit1024-202310xk047.jpg	Edgar Link	pending
exhibit1024-202310xk048.jpg	Edgar Link	pending
exhibit1024-202310xk049.jpg	Edgar Link	pending
exhibit1024-202310xk050.jpg	Edgar Link	pending
exhibit1024-202310xk051.jpg	Edgar Link	pending
exhibit1024-202310xk052.jpg	Edgar Link	pending
exhibit1024-202310xk053.jpg	Edgar Link	pending
exhibit1024-202310xk054.jpg	Edgar Link	pending
exhibit1024-202310xk055.jpg	Edgar Link	pending
exhibit1024-202310xk056.jpg	Edgar Link	pending
exhibit1024-202310xk057.jpg	Edgar Link	pending
exhibit1024-202310xk058.jpg	Edgar Link	pending
exhibit1024-202310xk059.jpg	Edgar Link	pending
exhibit1024-202310xk060.jpg	Edgar Link	pending
exhibit1024-202310xk061.jpg	Edgar Link	pending
exhibit1024-202310xk062.jpg	Edgar Link	pending
exhibit1024-202310xk063.jpg	Edgar Link	pending
exhibit1024-202310xk064.jpg	Edgar Link	pending
exhibit1024-202310xk065.jpg	Edgar Link	pending
exhibit1024-202310xk066.jpg	Edgar Link	pending
exhibit1024-202310xk067.jpg	Edgar Link	pending
exhibit1024-202310xk068.jpg	Edgar Link	pending
exhibit1024-202310xk069.jpg	Edgar Link	pending
exhibit1024-202310xk070.jpg	Edgar Link	pending
exhibit1024-202310xk071.jpg	Edgar Link	pending
exhibit1024-202310xk072.jpg	Edgar Link	pending
exhibit1024-202310xk073.jpg	Edgar Link	pending
exhibit1024-202310xk074.jpg	Edgar Link	pending
exhibit1024-202310xk075.jpg	Edgar Link	pending
exhibit1024-202310xk076.jpg	Edgar Link	pending
exhibit1024-202310xk077.jpg	Edgar Link	pending
exhibit1024-202310xk078.jpg	Edgar Link	pending
exhibit1024-202310xk079.jpg	Edgar Link	pending
exhibit1024-202310xk080.jpg	Edgar Link	pending
exhibit1024-202310xk081.jpg	Edgar Link	pending
exhibit1024-202310xk082.jpg	Edgar Link	pending
exhibit1024-202310xk083.jpg	Edgar Link	pending
exhibit1024-202310xk084.jpg	Edgar Link	pending
exhibit1024-202310xk085.jpg	Edgar Link	pending
exhibit1024-202310xk086.jpg	Edgar Link	pending
exhibit1024-202310xk087.jpg	Edgar Link	pending
exhibit1024-202310xk088.jpg	Edgar Link	pending
exhibit1024-202310xk089.jpg	Edgar Link	pending
exhibit1024-202310xk090.jpg	Edgar Link	pending
exhibit1024-202310xk091.jpg	Edgar Link	pending
exhibit1024-202310xk092.jpg	Edgar Link	pending
exhibit1024-202310xk093.jpg	Edgar Link	pending
exhibit1024-202310xk094.jpg	Edgar Link	pending
exhibit1024-202310xk095.jpg	Edgar Link	pending
exhibit1024-202310xk096.jpg	Edgar Link	pending
exhibit1024-202310xk097.jpg	Edgar Link	pending
exhibit1024-202310xk098.jpg	Edgar Link	pending
exhibit1024-202310xk099.jpg	Edgar Link	pending
exhibit1024-202310xk100.jpg	Edgar Link	pending
exhibit1024-202310xk101.jpg	Edgar Link	pending
exhibit1024-202310xk102.jpg	Edgar Link	pending
exhibit1024-202310xk103.jpg	Edgar Link	pending
exhibit1024-202310xk104.jpg	Edgar Link	pending
exhibit1024-202310xk105.jpg	Edgar Link	pending
exhibit1024-202310xk106.jpg	Edgar Link	pending
exhibit1024-202310xk107.jpg	Edgar Link	pending
exhibit1024-202310xk108.jpg	Edgar Link	pending
exhibit1024-202310xk109.jpg	Edgar Link	pending
exhibit1024-202310xk110.jpg	Edgar Link	pending
exhibit1024-202310xk111.jpg	Edgar Link	pending
exhibit1024-202310xk112.jpg	Edgar Link	pending
exhibit1024-202310xk113.jpg	Edgar Link	pending
exhibit1024-202310xk114.jpg	Edgar Link	pending
exhibit1024-202310xk115.jpg	Edgar Link	pending
exhibit1024-202310xk116.jpg	Edgar Link	pending
exhibit1024-202310xk117.jpg	Edgar Link	pending
exhibit1024-202310xk118.jpg	Edgar Link	pending
exhibit1024-202310xk119.jpg	Edgar Link	pending
exhibit1024-202310xk120.jpg	Edgar Link	pending
exhibit1024-202310xk121.jpg	Edgar Link	pending
exhibit1024-202310xk122.jpg	Edgar Link	pending
exhibit1024-202310xk123.jpg	Edgar Link	pending
exhibit1024-202310xk124.jpg	Edgar Link	pending
exhibit1024-202310xk125.jpg	Edgar Link	pending
exhibit1024-202310xk126.jpg	Edgar Link	pending
exhibit1024-202310xk127.jpg	Edgar Link	pending
exhibit1024-202310xk128.jpg	Edgar Link	pending
exhibit1024-202310xk129.jpg	Edgar Link	pending
exhibit1024-202310xk130.jpg	Edgar Link	pending
exhibit1024-202310xk131.jpg	Edgar Link	pending
exhibit1024-202310xk132.jpg	Edgar Link	pending
exhibit1024-202310xk133.jpg	Edgar Link	pending
exhibit1024-202310xk134.jpg	Edgar Link	pending
exhibit1024-202310xk135.jpg	Edgar Link	pending
exhibit1024-202310xk136.jpg	Edgar Link	pending
exhibit1024-202310xk137.jpg	Edgar Link	pending
exhibit1024-202310xk138.jpg	Edgar Link	pending
exhibit1024-202310xk139.jpg	Edgar Link	pending
exhibit1024-202310xk140.jpg	Edgar Link	pending
exhibit1024-202310xk141.jpg	Edgar Link	pending
exhibit1024-202310xk142.jpg	Edgar Link	pending
exhibit1024-202310xk143.jpg	Edgar Link	pending
exhibit1024-202310xk144.jpg	Edgar Link	pending
exhibit1024-202310xk145.jpg	Edgar Link	pending
exhibit1024-202310xk146.jpg	Edgar Link	pending
exhibit1024-202310xk147.jpg	Edgar Link	pending
exhibit1024-202310xk148.jpg	Edgar Link	pending
exhibit1024-202310xk149.jpg	Edgar Link	pending
exhibit1024-202310xk150.jpg	Edgar Link	pending
exhibit1024-202310xk151.jpg	Edgar Link	pending
exhibit1024-202310xk152.jpg	Edgar Link	pending
exhibit1024-202310xk153.jpg	Edgar Link	pending
exhibit1024-202310xk154.jpg	Edgar Link	pending
exhibit1024-202310xk155.jpg	Edgar Link	pending
exhibit1024-202310xk156.jpg	Edgar Link	pending
exhibit1024-202310xk157.jpg	Edgar Link	pending
exhibit1024-202310xk158.jpg	Edgar Link	pending
exhibit1024-202310xk159.jpg	Edgar Link	pending
exhibit1024-202310xk160.jpg	Edgar Link	pending
exhibit1024-202310xk161.jpg	Edgar Link	pending
exhibit1024-202310xk162.jpg	Edgar Link	pending
exhibit1024-202310xk163.jpg	Edgar Link	pending
exhibit1024-202310xk164.jpg	Edgar Link	pending
exhibit1024-202310xk165.jpg	Edgar Link	pending
exhibit1024-202310xk166.jpg	Edgar Link	pending
exhibit1024-202310xk167.jpg	Edgar Link	pending
exhibit1024-202310xk168.jpg	Edgar Link	pending
exhibit1024-202310xk169.jpg	Edgar Link	pending
exhibit1025-202310xk.htm	Edgar Link	pending
exhibit1025-202310xk001.jpg	Edgar Link	pending
exhibit1025-202310xk002.jpg	Edgar Link	pending
exhibit1025-202310xk003.jpg	Edgar Link	pending
exhibit1025-202310xk004.jpg	Edgar Link	pending
exhibit1025-202310xk005.jpg	Edgar Link	pending
exhibit1025-202310xk006.jpg	Edgar Link	pending
exhibit1025-202310xk007.jpg	Edgar Link	pending
exhibit1025-202310xk008.jpg	Edgar Link	pending
exhibit1025-202310xk009.jpg	Edgar Link	pending
exhibit1025-202310xk010.jpg	Edgar Link	pending
exhibit1025-202310xk011.jpg	Edgar Link	pending
exhibit1025-202310xk012.jpg	Edgar Link	pending
exhibit1025-202310xk013.jpg	Edgar Link	pending
exhibit1025-202310xk014.jpg	Edgar Link	pending
exhibit1025-202310xk015.jpg	Edgar Link	pending
exhibit1025-202310xk016.jpg	Edgar Link	pending
exhibit1025-202310xk017.jpg	Edgar Link	pending
exhibit1025-202310xk018.jpg	Edgar Link	pending
exhibit1025-202310xk019.jpg	Edgar Link	pending
exhibit1025-202310xk020.jpg	Edgar Link	pending
exhibit1025-202310xk021.jpg	Edgar Link	pending
exhibit1025-202310xk022.jpg	Edgar Link	pending
exhibit1025-202310xk023.jpg	Edgar Link	pending
exhibit1025-202310xk024.jpg	Edgar Link	pending
exhibit1025-202310xk025.jpg	Edgar Link	pending
exhibit1025-202310xk026.jpg	Edgar Link	pending
exhibit1025-202310xk027.jpg	Edgar Link	pending
exhibit1025-202310xk028.jpg	Edgar Link	pending
exhibit1025-202310xk029.jpg	Edgar Link	pending
exhibit1025-202310xk030.jpg	Edgar Link	pending
exhibit1025-202310xk031.jpg	Edgar Link	pending
exhibit1025-202310xk032.jpg	Edgar Link	pending
exhibit1025-202310xk033.jpg	Edgar Link	pending
exhibit1025-202310xk034.jpg	Edgar Link	pending
exhibit1025-202310xk035.jpg	Edgar Link	pending
exhibit1025-202310xk036.jpg	Edgar Link	pending
exhibit1025-202310xk037.jpg	Edgar Link	pending
exhibit1025-202310xk038.jpg	Edgar Link	pending
exhibit1025-202310xk039.jpg	Edgar Link	pending
exhibit1025-202310xk040.jpg	Edgar Link	pending
exhibit1025-202310xk041.jpg	Edgar Link	pending
exhibit1025-202310xk042.jpg	Edgar Link	pending
exhibit1025-202310xk043.jpg	Edgar Link	pending
exhibit1025-202310xk044.jpg	Edgar Link	pending
exhibit1025-202310xk045.jpg	Edgar Link	pending
exhibit1025-202310xk046.jpg	Edgar Link	pending
exhibit1025-202310xk047.jpg	Edgar Link	pending
exhibit1025-202310xk048.jpg	Edgar Link	pending
exhibit1025-202310xk049.jpg	Edgar Link	pending
exhibit1025-202310xk050.jpg	Edgar Link	pending
exhibit1025-202310xk051.jpg	Edgar Link	pending
exhibit1025-202310xk052.jpg	Edgar Link	pending
exhibit1025-202310xk053.jpg	Edgar Link	pending
exhibit1025-202310xk054.jpg	Edgar Link	pending
exhibit1025-202310xk055.jpg	Edgar Link	pending
exhibit1025-202310xk056.jpg	Edgar Link	pending
exhibit1025-202310xk057.jpg	Edgar Link	pending
exhibit1025-202310xk058.jpg	Edgar Link	pending
exhibit1025-202310xk059.jpg	Edgar Link	pending
exhibit1025-202310xk060.jpg	Edgar Link	pending
exhibit1025-202310xk061.jpg	Edgar Link	pending
exhibit1025-202310xk062.jpg	Edgar Link	pending
exhibit1025-202310xk063.jpg	Edgar Link	pending
exhibit1025-202310xk064.jpg	Edgar Link	pending
exhibit1025-202310xk065.jpg	Edgar Link	pending
exhibit1025-202310xk066.jpg	Edgar Link	pending
exhibit1025-202310xk067.jpg	Edgar Link	pending
exhibit1025-202310xk068.jpg	Edgar Link	pending
exhibit1025-202310xk069.jpg	Edgar Link	pending
exhibit1025-202310xk070.jpg	Edgar Link	pending
exhibit1025-202310xk071.jpg	Edgar Link	pending
exhibit1025-202310xk072.jpg	Edgar Link	pending
exhibit1025-202310xk073.jpg	Edgar Link	pending
exhibit1025-202310xk074.jpg	Edgar Link	pending
exhibit1025-202310xk075.jpg	Edgar Link	pending
exhibit1025-202310xk076.jpg	Edgar Link	pending
exhibit1025-202310xk077.jpg	Edgar Link	pending
exhibit1025-202310xk078.jpg	Edgar Link	pending
exhibit1025-202310xk079.jpg	Edgar Link	pending
exhibit1025-202310xk080.jpg	Edgar Link	pending
exhibit1025-202310xk081.jpg	Edgar Link	pending
exhibit1025-202310xk082.jpg	Edgar Link	pending
exhibit1025-202310xk083.jpg	Edgar Link	pending
exhibit1025-202310xk084.jpg	Edgar Link	pending
exhibit1025-202310xk085.jpg	Edgar Link	pending
exhibit1025-202310xk086.jpg	Edgar Link	pending
exhibit1025-202310xk087.jpg	Edgar Link	pending
exhibit1025-202310xk088.jpg	Edgar Link	pending
exhibit1025-202310xk089.jpg	Edgar Link	pending
exhibit1025-202310xk090.jpg	Edgar Link	pending
exhibit1025-202310xk091.jpg	Edgar Link	pending
exhibit1025-202310xk092.jpg	Edgar Link	pending
exhibit1025-202310xk093.jpg	Edgar Link	pending
exhibit1025-202310xk094.jpg	Edgar Link	pending
exhibit1025-202310xk095.jpg	Edgar Link	pending
exhibit1025-202310xk096.jpg	Edgar Link	pending
exhibit1025-202310xk097.jpg	Edgar Link	pending
exhibit1025-202310xk098.jpg	Edgar Link	pending
exhibit1025-202310xk099.jpg	Edgar Link	pending
exhibit1025-202310xk100.jpg	Edgar Link	pending
exhibit1025-202310xk101.jpg	Edgar Link	pending
exhibit1025-202310xk102.jpg	Edgar Link	pending
exhibit1025-202310xk103.jpg	Edgar Link	pending
exhibit1025-202310xk104.jpg	Edgar Link	pending
exhibit1025-202310xk105.jpg	Edgar Link	pending
exhibit1025-202310xk106.jpg	Edgar Link	pending
exhibit1025-202310xk107.jpg	Edgar Link	pending
exhibit1025-202310xk108.jpg	Edgar Link	pending
exhibit1025-202310xk109.jpg	Edgar Link	pending
exhibit1025-202310xk110.jpg	Edgar Link	pending
exhibit1025-202310xk111.jpg	Edgar Link	pending
exhibit1025-202310xk112.jpg	Edgar Link	pending
exhibit1025-202310xk113.jpg	Edgar Link	pending
exhibit1025-202310xk114.jpg	Edgar Link	pending
exhibit1025-202310xk115.jpg	Edgar Link	pending
exhibit1025-202310xk116.jpg	Edgar Link	pending
exhibit1025-202310xk117.jpg	Edgar Link	pending
exhibit1025-202310xk118.jpg	Edgar Link	pending
exhibit1025-202310xk119.jpg	Edgar Link	pending
exhibit1025-202310xk120.jpg	Edgar Link	pending
exhibit1025-202310xk121.jpg	Edgar Link	pending
exhibit1025-202310xk122.jpg	Edgar Link	pending
exhibit1025-202310xk123.jpg	Edgar Link	pending
exhibit1025-202310xk124.jpg	Edgar Link	pending
exhibit1025-202310xk125.jpg	Edgar Link	pending
exhibit1025-202310xk126.jpg	Edgar Link	pending
exhibit1025-202310xk127.jpg	Edgar Link	pending
exhibit1025-202310xk128.jpg	Edgar Link	pending
exhibit1025-202310xk129.jpg	Edgar Link	pending
exhibit1025-202310xk130.jpg	Edgar Link	pending
exhibit1025-202310xk131.jpg	Edgar Link	pending
exhibit1025-202310xk132.jpg	Edgar Link	pending
exhibit1025-202310xk133.jpg	Edgar Link	pending
exhibit1025-202310xk134.jpg	Edgar Link	pending
exhibit1025-202310xk135.jpg	Edgar Link	pending
exhibit1025-202310xk136.jpg	Edgar Link	pending
exhibit1025-202310xk137.jpg	Edgar Link	pending
exhibit1025-202310xk138.jpg	Edgar Link	pending
exhibit1025-202310xk139.jpg	Edgar Link	pending
exhibit1025-202310xk140.jpg	Edgar Link	pending
exhibit1025-202310xk141.jpg	Edgar Link	pending
exhibit1025-202310xk142.jpg	Edgar Link	pending
exhibit1025-202310xk143.jpg	Edgar Link	pending
exhibit1025-202310xk144.jpg	Edgar Link	pending
exhibit1025-202310xk145.jpg	Edgar Link	pending
exhibit1025-202310xk146.jpg	Edgar Link	pending
exhibit1025-202310xk147.jpg	Edgar Link	pending
exhibit1025-202310xk148.jpg	Edgar Link	pending
exhibit1025-202310xk149.jpg	Edgar Link	pending
exhibit1025-202310xk150.jpg	Edgar Link	pending
exhibit1025-202310xk151.jpg	Edgar Link	pending
exhibit1025-202310xk152.jpg	Edgar Link	pending
exhibit1025-202310xk153.jpg	Edgar Link	pending
exhibit1025-202310xk154.jpg	Edgar Link	pending
exhibit1025-202310xk155.jpg	Edgar Link	pending
exhibit1025-202310xk156.jpg	Edgar Link	pending
exhibit1025-202310xk157.jpg	Edgar Link	pending
exhibit1025-202310xk158.jpg	Edgar Link	pending
exhibit1025-202310xk159.jpg	Edgar Link	pending
exhibit1025-202310xk160.jpg	Edgar Link	pending
exhibit1025-202310xk161.jpg	Edgar Link	pending
exhibit1025-202310xk162.jpg	Edgar Link	pending
exhibit1025-202310xk163.jpg	Edgar Link	pending
exhibit1025-202310xk164.jpg	Edgar Link	pending
exhibit1025-202310xk165.jpg	Edgar Link	pending
exhibit1025-202310xk166.jpg	Edgar Link	pending
exhibit1025-202310xk167.jpg	Edgar Link	pending
exhibit1025-202310xk168.jpg	Edgar Link	pending
exhibit1025-202310xk169.jpg	Edgar Link	pending
exhibit1025-202310xk170.jpg	Edgar Link	pending
exhibit1025-202310xk171.jpg	Edgar Link	pending
exhibit1025-202310xk172.jpg	Edgar Link	pending
exhibit1025-202310xk173.jpg	Edgar Link	pending
exhibit1025-202310xk174.jpg	Edgar Link	pending
exhibit1025-202310xk175.jpg	Edgar Link	pending
exhibit1025-202310xk176.jpg	Edgar Link	pending
exhibit1025-202310xk177.jpg	Edgar Link	pending
exhibit1025-202310xk178.jpg	Edgar Link	pending
exhibit211-202310xk.htm	Edgar Link	pending
exhibit231-202310xk.htm	Edgar Link	pending
exhibit232-202310xk.htm	Edgar Link	pending
exhibit311-202310xk.htm	Edgar Link	pending
exhibit312-202310xk.htm	Edgar Link	pending
exhibit321-202310xk.htm	Edgar Link	pending
exhibit322-202310xk.htm	Edgar Link	pending
exhibit97-202310xk.htm	Edgar Link	pending
exhibit97-202310xk001.jpg	Edgar Link	pending
exhibit97-202310xk002.jpg	Edgar Link	pending
exhibit97-202310xk003.jpg	Edgar Link	pending
exhibit97-202310xk004.jpg	Edgar Link	pending
exhibit97-202310xk005.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thry-20231231.htm	Edgar Link	pending
thry-20231231.xsd	Edgar Link	pending
thry-20231231_g1.jpg	Edgar Link	pending
thry-20231231_def.xml	Edgar Link	unprocessable
thry-20231231_lab.xml	Edgar Link	unprocessable
thry-20231231_pre.xml	Edgar Link	unprocessable
thry-20231231_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
thry-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THRY
Thryv Holdings, Inc. Stock $thry

2024 Q1 Form 10-K Financial Statement

#000155673924000015 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THRY Thryv Holdings, Inc. Stock $thry

2024 Q1 Form 10-K Financial Statement

#000155673924000015 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THRY
Thryv Holdings, Inc. Stock $thry